A typical acute lymphoblastic leukemia JAK2 variant, R683G, causes an aggressive form of familial thrombocytosis when germline
Gonzalo Carreño‐Tarragona, Rosa Ayala(Hospital Universitario 12 De Octubre), Stefan N. Constantinescu(Ludwig Cancer Research), Joaquín Martínez‐López(Hospital Universitario 12 De Octubre), Elena Sebastián(Queen's University Belfast), Syonghyun Nam-Cha(Complejo Hospitalario Universitario de Albacete), Nieves López‐Muñoz, Julián Sevilla(University of Southern Denmark), Alberto Marín-Sánchez(Complejo Hospitalario Universitario de Albacete), Leila N. Varghese(Ludwig Cancer Research), Eva Heredero Gálvez(Hospital Municipal de Badalona)
Cited by 12
Related Papers
Teclistamab in Relapsed or Refractory Multiple Myeloma
|New England Journal of Medicine|2022|1.2k
Cilta-cel or Standard Care in Lenalidomide-Refractory Multiple Myeloma
|New England Journal of Medicine|2023|719
Second-Line Tisagenlecleucel or Standard Care in Aggressive B-Cell Lymphoma
|New England Journal of Medicine|2021|532
Tisagenlecleucel in adult relapsed or refractory follicular lymphoma: the phase 2 ELARA trial
|Nature Medicine|2021|523